BioCentury
ARTICLE | Company News

Seragen deal

August 8, 1994 7:00 AM UTC

Lilly purchased 787,092 common shares of SRGN at $6.35 per share, which represented a 10 percent premium to the market. SRGN has 16.2 million shares outstanding. ...